Noida, India (PressExposure) March 15, 2011 -- According to our new research report "Global Monoclonal Antibody Market Analysis", the global monoclonal antibodies (mAbs) market has been growing at a fast pace for the past few years. It has been found that the number of mAbs reaching the marketplace has exponentially increased and has resulted in a presence of significant developments in medical science. The market for monoclonal antibodies reached to the mark of around US$ 39.6 Billion in 2009 witnessing an annual growth rate of around 13%. As monoclonal antibodies offer several clinical advantages and versatility, the market is further likely to grow in future.
Our report has found that, monoclonal antibody therapy has emerged as a relatively new innovation in cancer treatment. Monoclonal antibodies have specificity for their target molecules and the ability to either activate or suppress the molecular function of the target, thus leading to enhanced immune response. Colorectal cancer had the largest 35% share in monoclonal antibody oncology market in 2009, followed by breast cancer at 32.5% share.
The report "Global Monoclonal Antibody Market Analysis" covers almost all the key aspects of the market and analyzes current market developments in regions, such as the United States, Europe, Japan, China, and India. Moreover, the report provides an analysis on major drugs in monoclonal antibody market and illustrates their sales patterns. Further, it also analyzes the key market alliances and acquisitions in recent times and describes their impact on the sector's profitability.
The report is an outcome of an in-depth research and prudent analysis of the global monoclonal antibody market, with significant emphasis on data reliability and content presentation. The report covers key application areas, where the use of monoclonal antibodies has strengthened during the past few years and analyzes their market potential. Last but not the least, description and recent developments of major industry players seek to enhance knowledge portfolio of our clients.
For FREE SAMPLE of this report visit: [http://www.rncos.com/Report/IM279.htm]
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm